Skip to main content.
OrganAID Holdings S.L.
Startup
-
Location
Hall 8.1 - 4YFN Stand 8.1C23.6A
Information
Biotech company that uses cerebral organoids, advanced 3D celular cultures that replicate human brain physiology to test drug safety and efficacy in vitro. These organoids are combined with ImPheNet AI tool trained on a large image database to predict drug response and toxicity. Our AI tool analyzes organoid morphology, transcriptomics and imaging data :
Phases: Diagnosis-Cell culture from Biopsy-Organoid formation and drug testing-Eficacy/toxicity prediction-Drug development-Personalized therapy
Modular solutions tailored to pharmaceutical, biotech and clinical R&D pipelines
Organoids production for internal testing
Toxicity and efficacy assessment
Indication selection & priority
Personalized medicine
Phases: Diagnosis-Cell culture from Biopsy-Organoid formation and drug testing-Eficacy/toxicity prediction-Drug development-Personalized therapy
Modular solutions tailored to pharmaceutical, biotech and clinical R&D pipelines
Organoids production for internal testing
Toxicity and efficacy assessment
Indication selection & priority
Personalized medicine
Key Information
-
CountrySpain
-
Founding Year2025